Shenzhenshi Limpidrop Technology Co., LTD. – Trademark Portfolio

Entity Type: 99

Shenzhenshi Limpidrop Technology Co., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LIMPIDROP. The owner is based in Longgang, Shenzhen.

308, Block C, Xinmubanli Bldg., No.321-3

Xinmu Rd., Xinmu Community, Pinghu St., 

Longgang, Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIMPIDROP
LIMPIDROP
Registered 2020

Trademark Classifications

Shenzhenshi Limpidrop Technology Co., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhenshi Limpidrop Technology Co., LTD. have?

Shenzhenshi Limpidrop Technology Co., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhenshi Limpidrop Technology Co., LTD. file in?

Shenzhenshi Limpidrop Technology Co., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhenshi Limpidrop Technology Co., LTD.'s most well-known trademarks?

Shenzhenshi Limpidrop Technology Co., LTD.'s registered trademark portfolio includes well-known marks such as LIMPIDROP. These are among 1 currently registered trademark in the portfolio.

What is Shenzhenshi Limpidrop Technology Co., LTD.'s trademark registration success rate?

Shenzhenshi Limpidrop Technology Co., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.